These results suggest that in a subpopulation of ALS patients, DCs can contribute to the inflammatory process by producing inflammatory chemokines, such as CCL-2 and IL-8, in the inflamed lymph nodes and CNS, and contributing to the recruitment of inflammatory cells, i. This evidence concerns the gene CCL2 and amyotrophic lateral sclerosis.